Ye, D., Song, S., Li, Y., Fan, W., Shi, H., Guo, J., Dong, Q., Huang, R., Wang, J., Qin, W., Wang, F., Yang, H., Yang, T., Xu, D., Yovine, A. J., Li, H., Li, J., Li, R., Huo, L., Ji, Z. (2026). The efficacy and safety of 177 Lu-PSMA-617 in Chinese patients with post-taxane metastatic castration-resistant prostate cancer: From a multicenter phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.181